King Faisal Specialist Hospital in Saudi Arabia internally produced CAR T-cells for cancer treatment at 80% lower cost.
King Faisal Specialist Hospital & Research Centre in Saudi Arabia has successfully produced Chimeric Antigen Receptor (CAR) T-cells internally for cancer treatment, reducing treatment costs by 80% to approximately 250,000 SAR per treatment. The breakthrough overcomes cost and shipping challenges, providing faster access to treatment and supporting national efforts to localize biotechnological industries. The hospital's internal T-cell manufacturing centre uses advanced bioreactors and cell processing units and is part of an ongoing strategy to develop advanced therapies and increase clinical research opportunities to enhance healthcare quality.
June 23, 2024
7 Articles